Receptor Tyrosine Kinase Signaling and Targeting in Glioblastoma Multiforme

Glioblastoma multiforme (GBM) is amongst the deadliest of human cancers, with a median survival rate of just over one year following diagnosis. Characterized by rapid proliferation and diffuse infiltration into the brain, GBM is notoriously difficult to treat, with tumor cells showing limited respon...

Descripción completa

Detalles Bibliográficos
Autores principales: Tilak, Manali, Holborn, Jennifer, New, Laura A., Lalonde, Jasmin, Jones, Nina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918566/
https://www.ncbi.nlm.nih.gov/pubmed/33673213
http://dx.doi.org/10.3390/ijms22041831

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7918566/
https://www.ncbi.nlm.nih.gov/pubmed/33673213
http://dx.doi.org/10.3390/ijms22041831

Ejemplares similares